TLR10 - Toll-Like Receptor 10
Introduction
TLR10 encodes Toll-Like Receptor 10, a member of the TLR family that is unique among human TLRs for several reasons. It is the only TLR gene located in a TLR gene cluster (with TLR1 and TLR6) on chromosome 4p14, and it represents the least characterized human TLR due to its lack of functional expression in commonly used model systems. Despite these challenges, emerging research indicates that TLR10 plays important roles in innate immunity, inflammation modulation, and potentially in neuroinflammatory conditions affecting the central nervous system[@chuang2001]. [@chuang2001]
<div class="infobox infobox-gene">
<div class="infobox-header">Gene Information</div> [@kim2019]
<div class="infobox-row">
<div class="infobox-label">Gene Symbol</div> [@lee2013]
<div class="infobox-value">TLR10</div>
</div>
<div class="infobox-row">
<div class="infobox-label">Full Name</div>
<div class="infobox-value">Toll-Like Receptor 10</div>
</div>
<div class="infobox-row">
<div class="infobox-label">Chromosomal Location</div>
<div class="infobox-value">4p14 (TLR gene cluster)</div>
</div>
<div class="infobox-row">
<div class="infobox-label">NCBI Gene ID</div>
<div class="infobox-value">[10334](https://www.ncbi.nlm.nih.gov/gene/10334)</div>
</div>
<div class="infobox-row">
<div class="infobox-label">OMIM</div>
<div class="infobox-value">[606215](https://omim.org/entry/606215)</div>
</div>
<div class="infobox-row">
<div class="infobox-label">Ensembl ID</div>
<div class="infobox-value">ENSG00000150045</div>
</div>
<div class="infobox-row">
<div class="infobox-label">UniProt</div>
<div class="infobox-value">[Q9RUF7](https://www.uniprot.org/uniprot/Q9RUF7)</div>
</div>
<div class="infobox-row">
<div class="infobox-label">Protein Family</div>
<div class="infobox-value">TLR1/2/6/10 subfamily</div>
</div>
<div class="infobox-row">
<div class="infobox-label">Associated Diseases</div>
<div class="infobox-value">Alzheimer's Disease, Parkinson's Disease, Autoimmune Disorders, Atherosclerosis, Tuberculosis</div>
</div>
</div>
Overview
TLR10 is a type I transmembrane pattern recognition receptor belonging to the TLR1/2/6/10 subfamily. Unlike other TLRs, TLR10 has proven difficult to study because it does not signal efficiently in standard cell lines, and for many years it was considered a pseudogene in mice. However, human TLR10 is a functional receptor with distinct characteristics:
- Co-receptor function: Acts primarily as a co-receptor rather than a primary pattern recognition receptor
- Modulatory effects: Can inhibit signaling from TLR2-containing heterodimers
- Adaptive immunity: Involved in B cell responses and antibody production
- Brain expression: Present in [microglia](/cell-types/microglia-neuroinflammation) and other brain cells
The unique genomic organization of TLR10, TLR1, and TLR6 in a tandem array suggests they evolved through gene duplication and may have overlapping or compensatory functions.
Protein Structure and Function
Domain Architecture
TLR10 contains the characteristic TLR domain organization:
Leucine-Rich Repeat (LRR) domain: Extracellular region containing 20-25 LRRs
- LRR CT (C-terminal): Ligand recognition
- LRRs: Non-consecutive repeats of LxxLxLxxN motif
- N-glycosylation sites for proper folding
Transmembrane domain: Single pass α-helical segment
- Position: Amino acids 600-620
- Anchors receptor in plasma membrane/endosomal membrane
TIR (Toll/IL-1 Receptor) domain: Cytoplasmic signaling domain
- BB loop: Critical for adapter protein interactions
- Conserved motifs: Box 1 and Box 2
Structural Features Unique to TLR10
- LRR 3: Contains an insertion unique among TLRs
- TIR domain: Has specific residues that affect signaling
- Glycosylation: Multiple N-linked glycosylation sites
Signaling Mechanisms
TLR10 signaling is complex and differs from other TLRs:
MyD88-Dependent Pathway (primary):
- TLR10 recruits MyD88 through TIR domain interactions
- Activates IRAK4, IRAK1/2, TRAF6
- Leads to [NF-κB](/entities/nf-kb) and MAPK activation
- Results in pro-inflammatory cytokine production
Negative Regulation:
- TLR10 can inhibit TLR2/TLR1 and TLR2/TLR6 signaling
- Acts as a decoy receptor in some contexts
- May regulate excessive inflammation
B Cell-Specific Signaling:
- Associates with B cell receptor complex
- Enhances antibody responses to certain antigens
- Requires co-localization in lipid rafts
Brain Expression and Function
Cellular Distribution
| Cell Type | Expression Level | Functional Role |
|-----------|-----------------|----------------|
| Microglia | Low-Moderate | Neuroinflammation modulation |
| [Astrocytes](/entities/astrocytes) | Low | Stress response |
| [Neurons](/entities/neurons) | Very Low | Limited expression |
| Oligodendrocytes | Very Low | Not well characterized |
| Perivascular macrophages | Moderate | Immune surveillance |
Regional Expression
TLR10 expression in the brain is lower than other TLRs (TLR2, TLR4) but is detectable in:
- Cerebral [cortex](/brain-regions/cortex)
- [Hippocampus](/brain-regions/hippocampus) (particularly CA1 and dentate gyrus)
- Cerebellum
- Substantia nigra
Functions in the CNS
Microglial activation: Modulates cytokine production in response to pathogens
Neuroprotection: May have anti-inflammatory effects through heterodimer inhibition
Disease modification: Genetic variants may alter brain inflammatory responsesDisease Associations
Alzheimer's Disease
Association: TLR10 genetic variants have been linked to AD risk in some populations[@zhang2018]
Mechanisms:
- Recognition of amyloid-associated microbial components
- Modulation of microglial inflammatory responses
- Potential role in amyloid clearance
- Interaction with TLR2/TLR6 heterodimers
Evidence:
- GWAS studies have identified TLR10 polymorphisms associated with AD
- Expression studies show altered TLR10 in AD brain
- In vitro models suggest role in Aβ-induced inflammation
Parkinson's Disease
Association: TLR10 implicated in PD pathogenesis[@kim2019]
Mechanisms:
- Recognition of [α-synuclein](/proteins/alpha-synuclein) aggregates
- Modulation of microglial responses to neuron-derived proteins
- Potential involvement in Lewy body formation
Evidence:
- TLR10 expression increased in PD substantia nigra
- Polymorphisms associated with PD risk in some studies
Autoimmune Disorders
Association: Altered TLR10 in various autoimmune conditions
Specific Associations:
- Systemic lupus erythematosus (SLE)
- Rheumatoid arthritis
- Inflammatory bowel disease
Mechanism: Dysregulated TLR10 may contribute to autoimmunity through altered immune cell activation thresholds.
Atherosclerosis
Association: TLR10 plays roles in cardiovascular disease
Mechanisms:
- Recognition of oxidized lipids
- Modulation of plaque inflammation
- Effects on endothelial cell activation
Tuberculosis
Association: TLR10 variants influence TB susceptibility
Evidence:
- Specific SNPs associated with protection or susceptibility
- Different allele frequencies in TB patient populations
Genetic Variants
Polymorphisms
| SNP | Location | Function | Disease Association |
|-----|----------|----------|---------------------|
| rs5743809 | Promoter | Altered expression | TB susceptibility |
| rs5743810 | Coding (V321I) | Missense | Modified signaling |
| rs10856839 | Intron | Unknown | AD risk |
| rs4696480 | Promoter | Transcription factor binding | Autoimmune disease |
Functional Variants
- rs5743810:编码 change affecting TIR domain signaling
- rs5743809: Promoter variant affecting basal expression
- Haplotype variants: Specific combinations associated with disease
Therapeutic Implications
Targeting TLR10
| Strategy | Approach | Development Status |
|----------|----------|---------------------|
| Agonists | Synthetic TLR10 ligands | Preclinical |
| Antagonists | Blocking antibodies | Research |
| Gene therapy | Expression modulation | Early stage |
| SNPs | Personalized medicine | Investigation |
Therapeutic Potential
Anti-inflammatory therapy: TLR10 agonists could reduce excessive inflammation
Autoimmune modulation: TLR10 targeting in B cell-mediated autoimmunity
Neurodegeneration: Modulating brain inflammation
Infectious disease: Enhancing antimicrobial immunityChallenges
- Limited understanding of TLR10 ligands
- Complexity of signaling networks
- Species differences in TLR10 function
- Lack of specific pharmacological tools
Experimental Systems
- Cell lines: HEK293 (with MyD88), B cell lines
- Primary cells: Human monocytes, B cells, microglia
- Animal models: Transgenic mice expressing human TLR10
Ligand Identification
Known and potential TLR10 ligands include:
- Synthetic TLR10-specific agonists
- Lipoproteins from various pathogens
- [Heat shock proteins](/entities/heat-shock-proteins) (controversial)
- [Amyloid-beta](/proteins/amyloid-beta) (in the context of AD)
Comparison with TLR1 and TLR6
TLR10 is most closely related to TLR1 and TLR6:
| Feature | TLR10 | TLR1 | TLR6 |
|---------|-------|------|------|
| Chromosome | 4p14 | 4p14 | 4p14 |
| Heterodimers | TLR2 | TLR2 | TLR2 |
| Signaling | MyD88 | MyD88 | MyD88 |
| Ligand specificity | Limited | Triacylated lipoproteins | Diacylated lipoproteins |
| Brain expression | Low | Moderate | Moderate |
Unanswered Questions
What are the specific physiological ligands of TLR10?
How does TLR10 signaling differ between cell types?
Can TLR10 modulation treat inflammatory diseases?
What is the role of TLR10 in normal brain function?
How do TLR10 variants affect disease risk?See Also
- [Toll-Like Receptors](/mechanisms/toll-like-receptor-signaling)
- [TLR1](/genes/tlr1)
- [TLR2](/genes/tlr2)
- [TLR6](/genes/tlr6)
- [Neuroinflammation](/mechanisms/neuroinflammation-pathway)
- [Microglia](/cell-types/microglia)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- Innate Immune Signaling
External Links
- [NCBI Gene: TLR10](https://www.ncbi.nlm.nih.gov/gene/10334)
- [UniProt: TLR10](https://www.uniprot.org/uniprot/Q9RUF7)
- [Ensembl: TLR10](https://www.ensembl.org/Homo_sapiens/ENSG00000150045)
- [OMIM: TLR10](https://omim.org/entry/606215)
References
Chuang T, Ulevitch RJ, Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells (2001)
Zhang Y, et al, Toll-like receptor polymorphisms and Alzheimer's disease: a systematic review and meta-analysis (2018)
Kim C, et al, Toll-like receptors in neurodegenerative diseases (2019)
Hasan U, et al, Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene expression through MyD88 (2005)
Lee SM, et al, TLR10 modulates innate immune responses to Mycobacterium tuberculosis (2013)